Antiemetic effectiveness and safety of aprepitant in patients with lung cancer receiving combination therapy with carboplatin.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2016
At a glance
- Drugs Aprepitant (Primary) ; Antiemetics
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 15 Feb 2013 New trial record